Rankings
▼
Calendar
ANIK Q2 2024 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$31M
-30.6% YoY
Gross Profit
$20M
66.7% margin
Operating Income
-$2M
-5.9% margin
Net Income
-$88,000
-0.3% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
-24.2%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$4M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$263M
Total Liabilities
$52M
Stockholders' Equity
$210M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$44M
-30.6%
Gross Profit
$20M
$29M
-29.3%
Operating Income
-$2M
-$4M
+50.2%
Net Income
-$88,000
-$3M
+96.8%
Revenue Segments
Joint Preservation and Restoration
$14M
89%
Non-Orthopedic
$2M
11%
Geographic Segments
UNITED STATES
$29M
81%
Europe
$7M
19%
← FY 2024
All Quarters
Q3 2024 →